BRIDGET BONELLO: Open Payments
NPI 1184942138 · WYANDOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,347 in 118 payments from 15 companies in 2025. Trend: 2023 $2,026 · 2024 $2,582 · 2025 $3,347
Food & beverage: $3,258Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $808 |
| Janssen Biotech, Inc. | 21 | $676 |
| Regeneron Healthcare Solutions, Inc. | 10 | $315 |
| Ardelyx, Inc. | 12 | $274 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $200 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $187 |
| PFIZER INC. | 7 | $174 |
| Janssen Scientific Affairs, LLC | 1 | $132 |
| Madrigal Pharmaceuticals | 1 | $130 |
| Phathom Pharmaceuticals, Inc. | 2 | $124 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, IBSRELA, RINVOQ, XIFAXAN, ENTYVIO, REZDIFFRA.
Industry payments across MI — which companies pay providers there.
